Phosplatin Therapeutics is harnessing immunogenic cell death (ICD) as an alternative mechanism to existing cancer immunotherapy ... and in combination therapy with PD-L1 immune checkpoint ...

Harnessing immunogenic cell death (ICD)—an immunostimulatory ... is designed to offer a safe and effective therapy to cancer patients with limited treatment options,” said Robert Fallon ...

The latest findings on the interaction between cell death and cellular senescence in cancer and their pathophysiological significance have been reviewed by a team led by Osaka Metropolitan University ...

Aging cells secrete substances known to promote the growth of cancer cells. The development of drugs that can selectively kill these cells or inhibit the secretion of substances is ongoing.

Radiation therapy (also called radiotherapy) is a critically important type of cancer treatment ... Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage. Nat Cell Biol.

Scientists at Children's Medical Research Institute (CMRI) have solved a big mystery in cancer research ... recombination promotes non-immunogenic mitotic cell death upon DNA damage, Nature ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a ...

Researchers found that radiotherapy may reduce immune cells in the tumor-immune microenvironment, potentially impacting ...

Although effective, enzyme inhibitors frequently face limitations such as treatment resistance ... Leads to ERK Dysregulation and Immunogenic Cancer Cell Death”, published in Nature ...

The study is based on the analysis of human senescent cells in a specific tumor model — melanoma, which affects skin cells known as melanocytes — and, more specifically, melanocytes exposed to ...

In cancer treatment, patients who undergo ... In addition, they can activate an abscopal effect, inducing immunogenic cell ...